354 related articles for article (PubMed ID: 29301530)
1. Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN.
Xu Q; Cao S; Rajapakse S; Matsubara JA
Lipids Health Dis; 2018 Jan; 17(1):3. PubMed ID: 29301530
[TBL] [Abstract][Full Text] [Related]
2. Function and Dysfunction of Complement Factor H During Formation of Lipid-Rich Deposits.
Meri S; Haapasalo K
Front Immunol; 2020; 11():611830. PubMed ID: 33363547
[TBL] [Abstract][Full Text] [Related]
3. The complement system in age-related macular degeneration.
Armento A; Ueffing M; Clark SJ
Cell Mol Life Sci; 2021 May; 78(10):4487-4505. PubMed ID: 33751148
[TBL] [Abstract][Full Text] [Related]
4. Age-related macular degeneration and the complement system.
Khandhadia S; Cipriani V; Yates JR; Lotery AJ
Immunobiology; 2012 Feb; 217(2):127-46. PubMed ID: 21868123
[TBL] [Abstract][Full Text] [Related]
5. The impact of lipids, lipid oxidation, and inflammation on AMD, and the potential role of miRNAs on lipid metabolism in the RPE.
Jun S; Datta S; Wang L; Pegany R; Cano M; Handa JT
Exp Eye Res; 2019 Apr; 181():346-355. PubMed ID: 30292489
[TBL] [Abstract][Full Text] [Related]
6. The complement system and age-related macular degeneration.
Sivaprasad S; Chong NV
Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
[TBL] [Abstract][Full Text] [Related]
7. Interrelation Between Oxidative Stress and Complement Activation in Models of Age-Related Macular Degeneration.
Pujol-Lereis LM; Schäfer N; Kuhn LB; Rohrer B; Pauly D
Adv Exp Med Biol; 2016; 854():87-93. PubMed ID: 26427398
[TBL] [Abstract][Full Text] [Related]
8. The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells.
Dasari B; Prasanthi JR; Marwarha G; Singh BB; Ghribi O
BMC Ophthalmol; 2010 Sep; 10():22. PubMed ID: 20836858
[TBL] [Abstract][Full Text] [Related]
9. Implications of genetic variation in the complement system in age-related macular degeneration.
de Jong S; Gagliardi G; Garanto A; de Breuk A; Lechanteur YTE; Katti S; van den Heuvel LP; Volokhina EB; den Hollander AI
Prog Retin Eye Res; 2021 Sep; 84():100952. PubMed ID: 33610747
[TBL] [Abstract][Full Text] [Related]
10. Complement activation as a biomarker for Alzheimer's disease.
Aiyaz M; Lupton MK; Proitsi P; Powell JF; Lovestone S
Immunobiology; 2012 Feb; 217(2):204-15. PubMed ID: 21856034
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration.
Cooke Bailey JN; Pericak-Vance MA; Haines JL
Cold Spring Harb Perspect Med; 2014 Sep; 4(12):a017186. PubMed ID: 25213188
[TBL] [Abstract][Full Text] [Related]
12. Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration.
Suzuki M; Tsujikawa M; Itabe H; Du ZJ; Xie P; Matsumura N; Fu X; Zhang R; Sonoda KH; Egashira K; Hazen SL; Kamei M
J Cell Sci; 2012 May; 125(Pt 10):2407-15. PubMed ID: 22357958
[TBL] [Abstract][Full Text] [Related]
13. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
Richards A; Kavanagh D; Atkinson JP
Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease.
Lashkari K; Teague G; Chen H; Lin YQ; Kumar S; McLaughlin MM; López FJ
PLoS One; 2018; 13(5):e0195751. PubMed ID: 29782502
[TBL] [Abstract][Full Text] [Related]
15. Genetics of immunological and inflammatory components in age-related macular degeneration.
Tuo J; Grob S; Zhang K; Chan CC
Ocul Immunol Inflamm; 2012 Feb; 20(1):27-36. PubMed ID: 22324898
[TBL] [Abstract][Full Text] [Related]
16. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.
Geerlings MJ; de Jong EK; den Hollander AI
Mol Immunol; 2017 Apr; 84():65-76. PubMed ID: 27939104
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms of Complement System Proteins and Matrix Metalloproteinases in the Pathogenesis of Age-Related Macular Degeneration.
Mansoor N; Wahid F; Azam M; Shah K; den Hollander AI; Qamar R; Ayub H
Curr Mol Med; 2019; 19(10):705-718. PubMed ID: 31456517
[TBL] [Abstract][Full Text] [Related]
18. Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study.
Cougnard-Grégoire A; Delyfer MN; Korobelnik JF; Rougier MB; Le Goff M; Dartigues JF; Barberger-Gateau P; Delcourt C
PLoS One; 2014; 9(3):e90973. PubMed ID: 24608419
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory biomarkers for AMD.
Stanton CM; Wright AF
Adv Exp Med Biol; 2014; 801():251-7. PubMed ID: 24664705
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.
Parmeggiani F; Sorrentino FS; Romano MR; Costagliola C; Semeraro F; Incorvaia C; D'Angelo S; Perri P; De Nadai K; Bonomo Roversi E; Franceschelli P; Sebastiani A; Rubini M
Mediators Inflamm; 2013; 2013():435607. PubMed ID: 24369445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
